CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)
$9.13 0.43 (4.9425%)
Analysed CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) News Sources
Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ...
05-08-2026
yahoo.com
The Zacks Analyst Blog Highlights Alphabet, Apple, Micron Technology, Cumberland Pharmaceuticals and AmeriServ Financial
28-05-2026
yahoo.com
Cumberland Pharmaceuticals Q1 Earnings Call Highlights
05-05-2026
marketbeat.com
Cumberland Pharmaceuticals Inc. Q1 2026 Earnings Call Summary
06-05-2026
moby.co
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan
06-05-2026
yahoo.com
Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
26-06-2026
yahoo.com
Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex
01-07-2026
yahoo.com
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
01-07-2026
yahoo.com
/C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./
13-07-2026
yahoo.com
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
28-07-2026
yahoo.com
What is the current price of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The current price of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is $9.13.
CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) since the previous trading day is $0.43.
CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) since the previous trading day is 4.9425%.
What is the most recent average sentiment score for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The most recent average sentiment score for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The most recent sentiment for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is .
SEC-8K** Filing Available For CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.